JAB-2485 Activity in Adult Patients With Advanced Solid Tumors

Clinical trial NCT05490472 · RECRUITING

Trial details

NCT number: NCT05490472
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors ER+ Breast Cancer Triple Negative Breast Cancer, TNBC ARID1A Gene Mutation Small Cell Lung Cancer, SCLC

Start date: 2022-12-20
Primary completion: 2026-08-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.